260
Views
51
CrossRef citations to date
0
Altmetric
Original

Sexual dimorphism in disease onset and progression of a rat model of ALS

, , , , , , & show all
Pages 20-25 | Received 14 Dec 2005, Accepted 26 Aug 2006, Published online: 10 Jul 2009

References

  • Brownell B., Oppenheimer D. R., Hughes J. T. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970; 33: 338–57
  • Brown R. H Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80: 687–92
  • Cleveland D. W., Rothstein J. D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001; 2: 806–19
  • Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62
  • Shaw C. E., Enayat Z. E., Powell J. F., Anderson V. E., Radunovic A., al Sarraj S., Leigh P. N. Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation. Neurology 1997; 49: 1612–6
  • Orrell R. W. Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations. Neuromuscul Disord 2000; 10: 63–8
  • Andersen P. M., Sims K. B., Xin W. W., Kiely R., O'Neill G., Ravits J., et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 62–73
  • Gurney M. E., Pu H., Chiu A. Y., Dal Canto M. C., Polchow C. Y., Alexander D. D., et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 1994; 264: 1772–5
  • Nagai M., Aoki M., Miyoshi I., Kato M., Pasinelli P., Kasai N., et al. Rats expressing human cytosolic Cu/Zn superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 2001; 21: 9246–54
  • Howland D. S., Liu J., She Y., Goad B., Maragakis N. J., Kim B., et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant‐mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci. U S A 2002; 99: 1604–9
  • Klein S. M., Behrstock S., McHugh J., Hoffmann K., Wallace K., Suzuki M., et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 2005; 16: 509–21
  • Llado J., Haenggeli C., Pardo A., Wong V., Benson L., Coccia C., et al. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiol Dis 2006; 21: 110–18
  • Storkebaum E., Lambrechts D., Dewerchin M., Moreno‐Murciano M. P., Appelmans S., Oh H., et al. Treatment of motor neuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 2005; 8: 85–92
  • Chio A., Meineri P., Tribolo A., Schiffer D. Risk factors in motor neuron disease: a case‐control study. Neuroepidemiology 1991; 10: 174–84
  • Haverkamp L. J., Appel V., Appel S. H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707–19
  • Veldink J. H., Bar P. R., Joosten E. A., Otten M., Wokke J. H., van den Berg L. H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord 2003; 13: 737–43
  • Basso D. M., Beattie M. S., Bresnahan J. C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1–21
  • Current Protocols in Neuroscience, J. N Crawley, C Gerfen, R McKay, M Rogawski, D Sibley, P Skolnick. John Wiley & Sons Inc., New York 1997
  • Nakamizo T., Urushitani M., Inoue R., Shinohara A., Sawada H., Honda K., et al. Protection of cultured spinal motor neurons by estradiol. Neuroreport 2000; 11: 3493–7
  • Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 2002; 3: 433–42
  • Bar P. R., Amelink G. J. Protection against muscle damage exerted by oestrogen: hormonal or antioxidant action?. Biochem Soc Trans 1997; 25: 50–4
  • Groeneveld G. J., van Muiswinkel F. L., Sturkenboom J. M., Wokke J. H., Bar P. R., van den Berg L. H. Ovariectomy and 17beta‐estradiol modulate disease progression of a mouse model of ALS. Brain Res 2004; 1021: 128–31
  • Militello A., Vitello G., Lunetta C., Toscano A., Maiorana G., Piccoli T., La B. V. The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. J Neurol Sci 2002; 195: 67–70

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.